Advertisement

Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Product › Details

Erbitux®

Products Next higher product group cetuximab
Period Status 2004-07-01 sales start
  Annual sales USD 2,016,000,000 (sales (2013) 2013)
Organisations Organisation Merck KGaA
  Group Merck (DE) (Group)
  Organisation 2 ImClone Systems Inc.
  Group Eli Lilly (Group)
  Original research Weizmann Institute of Science
Document Source Merck KGaA. (3/2/20). "Press Release: Erbitux Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Not intended for UK-based media]". Darmstadt.
     

   
Record changed: 2020-03-11

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for antibody cancer drug


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top